France Cancer Barometer - Cross-Sectional Study on Patients Treated in French Healthcare Institutions
Head :
Bonnelye Geneviève
Chabernaud Hélène
Chabernaud Hélène
Last update : 07/15/2015 | Version : 1 | ID : 8876
| General | |
| Identification | |
| Detailed name | Cross-Sectional Study on Patients Treated in French Healthcare Institutions |
| Sign or acronym | France Cancer Barometer |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | 1493177 |
| General Aspects | |
| Medical area |
Cancer research Hematology |
| Pathology (details) | By body: epidemiology, current treatments, stage at diagnosis, current stage, patient characteristics (age, sex, ECOG), clinical profile of disease (histology, changes, metastases, etc.) |
| Health determinants |
Iatrogenic Medicine |
| Keywords | clinical profile, agents (chemotherapy/targeted therapy), haematology, oncology, therapeutic strategies |
| Scientific investigator(s) (Contact) | |
| Name of the director | Bonnelye |
| Surname | Geneviève |
| Address | 138 avenue Marx Dormoy - 92120 Montrouge |
| Phone | + 33 (0)1 40 92 47 58 |
| genevieve.bonnelye@kantarhealth.com | |
| Organization | Kantar Health |
| Name of the director | Chabernaud |
| Surname | Hélène |
| Address | 138 avenue Marx Dormoy - 92120 Montrouge |
| Phone | + 33 (0)1 40 92 24 33 |
| Helene.Chabernaud@Kantarhealth.com | |
| Organization | Kantar Health |
| Collaborations | |
| Funding | |
| Funding status |
Private |
| Details | Kantar Health |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Kantar Health France |
| Organisation status |
Private |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Repeated cross-sectional studies (except case control studies) |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | quotas |
| Database objective | |
| Main objective | To determine the epidemiology, clinical profile and therapeutic strategies across 18 procedures (oncology and haematology). |
| Inclusion criteria | Patients currently treated within the active cancer population. |
| Population type | |
| Age |
Newborns (birth to 28 days) Infant (28 days to 2 years) Early childhood (2 to 5 years) Childhood (6 to 13 years) Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Gender |
Male Woman |
| Geography area |
National |
| Detail of the geography area | France |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 1993 |
| Date of last collection (YYYY or MM/YYYY) | 2013 |
| Size of the database | |
| Size of the database (number of individuals) |
[1000-10 000[ individuals |
| Details of the number of individuals | 4,430 |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data Declarative data Biological data |
| Clinical data (detail) |
Direct physical measures |
| Details of collected clinical data | metastases, stage, treatment |
| Declarative data (detail) |
Paper self-questionnaire Face to face interview |
| Biological data (detail) | changes, histology |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/morbidity Quality of life/health perception Others |
| Quality of life/perceived health (detail) | administration criteria, support treatment, healthcare locations, associated anti-tumour treatment, clinical profile (histology, changes, metastases, procedures, stage at diagnosis and current stage).) |
| Other (detail) | administration criteria, support treatment, healthcare locations, associated anti-tumour treatment, clinical profile (histology, changes, metastases, procedures, stage at diagnosis and current stage). |
| Procedures | |
| Data collection method | Face-to-face/self-administered questionnaire/registry/patient data sheets Data collected every 2 years |
| Quality procedure(s) used | ISO 20-232 |
| Participant monitoring |
No |
| Links to administrative sources |
Yes |
| Linked administrative sources (detail) | DREES |
| Promotion and access | |
| Promotion | |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Contact the scientist in charge at Kantar Health France. |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
